https://www.selleckchem.com/pr....oducts/gsk3326595-ep
the PST arm together with less reported use of the NHS in the PST arm (average £212 than with TAU-only (£2878). The feasibility trial achieved its objectives despite considerable difficulties with recruitment-adapting the PST, training a therapist, recruiting patients who had recently self-harmed, delivering the therapy, and establishing primary and secondary outcomes. These data provide a robust platform for a definitive multicentre randomised controlled trial of brief problem-solving therapy after hospital attendance du